Pharmaceuticals

Pentavalent Market Surges With Increasing Diphtheria Incidence Is Supporting Development Across The Pentavalent Market

May 20, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Is The Expected Market Value Outlook For The Pentavalent Market Through 2030?

The pentavalent market size has demonstrated consistent expansion in recent years. It is anticipated to increase from $2.7 billion in 2025 to $2.83 billion in 2026, at a compound annual growth rate (CAGR) of 4.6%. The historical growth in this market can be linked to several factors, including rising infant mortality rates, limited access to vaccines, the prevalence of rotavirus infections, government vaccination initiatives, and global public health campaigns.

The pentavalent market size is projected to experience consistent expansion in the coming years. It is anticipated to reach $3.39 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 4.7%. This anticipated growth throughout the forecast period stems from factors such as technological progress in vaccine creation, rising healthcare spending, the broadening of immunization initiatives in emerging nations, collaborations among pharmaceutical firms, and the adoption of digital tracking systems for vaccine distribution. Key trends identified for the forecast timeframe encompass a surge in infant immunization campaigns, governmental financial support for vaccine innovation, the enhancement of public health facilities, a heightened understanding of rotavirus prevention, and the progression of cold chain logistics.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9104&type=smp

Which Major Factors Are Contributing To The Development Of The Pentavalent Market?

The escalating occurrence of diphtheria is anticipated to stimulate the expansion of the pentavalent market. Diphtheria is a grave and highly infectious illness caused by the bacterium Corynebacterium diphtheriae, which can result in severe difficulties with eating and breathing, as well as the possibility of skin ulcers. The pentavalent vaccine provides protection against Diphtheria for children through a 3-dose immunization schedule, consequently leading to an increased demand for pentavalent vaccines due to the rising prevalence of diphtheria. For instance, in July 2025, according to the European Centre for Disease Prevention and Control, a Europe-based government agency, in Germany a total of 126 laboratory-confirmed cases of C. diphtheriae ST574 have been identified across the country with 55 cases in 2022, 49 cases in 2023, 18 cases in 2024 and at least 4 cases in 2025. This surge in diphtheria cases is therefore driving the growth of the pentavalent market.

Which Segment Groups Define The Pentavalent Market Landscape?

The pentavalent market covered in this report is segmented –

1) By Type: Pentavalent Vaccines (DTP-HepB-Hib combination), Other Combination Vaccines

2) By Formulation Type: Lyophilized, Liquid

3) By Application: Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Pentavalent Vaccines (DTP-HepB-Hib combination): DTP-HepB-Hib (Whole Cell), DTP-HepB-Hib (Acellular)

2) By Other Combination Vaccines: Hexavalent Vaccines

What Trends Are Shaping The Pentavalent Market Structure?

Major companies within the pentavalent market are concentrating on developing innovative solutions, such as pentavalent immunization vaccines. These vaccines are a type of combination vaccine formulated to protect against five different diseases. For instance, in October 2023, Pfizer, a US-based pharmaceutical company, announced that its ‘Penbraya’ pentavalent vaccine had received FDA approval. This vaccine is the initial and sole pentavalent vaccine offering protection against the five most prevalent meningococcal serogroups, namely A, B, C, W-135, and Y, in individuals aged 10 through 25 years. The vaccine merges components from the Trumenba meningococcal group B vaccine and the Nimenrix meningococcal groups A, C, W-135, and Y conjugate vaccine. Penbraya has been identified as effective in providing protection against the five meningococcal serogroups responsible for the majority of global cases of invasive meningococcal disease.

Who Are The Major Companies Operating In The Pentavalent Market?

Major companies operating in the pentavalent market are Pfizer Inc., Merck & Co Inc., Sanofi SA, GlaxoSmithKline plc, Shandong Xinhua Pharmaceutical Company Limited, PT Bio Farma (Persero), Shantha Biotechnics Limited, Biological E. Limited, Serum Institute of India Private Limited, Indian Immunologicals Limited, Incepta Pharmaceuticals Limited, Shanghai Institute of Biological Products Co Ltd., Changchun Changsheng Biotechnology Co Ltd., Adimmune Corporation, AJ Vaccines, Albert David Limited, PanGen Biotech Inc., Bharat Biotech International Limited, Vacsera Ltd., Pasteur Institute of India, Zydus Cadila Healthcare Limited, EuBiologics Co Ltd.

Access The Complete Pentavalent Market Report:

https://www.thebusinessresearchcompany.com/report/pentavalent-global-market-report

Which Region Is The Dominant Market In The Pentavalent Market?

Asia-Pacific was the largest region in the pentavalent market in 2025. The regions covered in the pentavalent market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Pentavalent Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=9104&type=smp

Browse Through More Reports Similar to the Global Pentavalent Market 2026, By The Business Research Company

Pentavalent Market Report 2026

https://www.thebusinessresearchcompany.com/report/pentavalent-global-market-report

Pentavalent Market Report 2026

https://www.thebusinessresearchcompany.com/report/pentavalent-global-market-report

Quadrivalent Market Report 2026

https://www.thebusinessresearchcompany.com/report/quadrivalent-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795